The American Academy of Pediatrics issued new guidelines yesterday upholding that central role of medications accompanied by behavioral therapy in ADHD treatment.

Experimental surgeries to prevent seizures may help scientists understand the link between autism and epilepsy.

Researcher Randi Hagerman is a big proponent of metformin — a diabetes drug that she is testing in people with fragile X syndrome. In fact, Hagerman takes the drug herself as a preventive measure against cancer.

A behavioral therapy called pivotal response treatment may boost the communication skills of autistic children with language delay better than do standard speech and autism therapies.

Researchers have created a microscopic particle that traps immune molecules found in a woman that are linked to autism in her child.

A drug that treats tumors and epilepsy in people with tuberous sclerosis complex does not boost their intelligence or ease autism traits.

People tend to believe that, regardless of the treatment, more is always better. But is it?

Watch the complete replay of Mark Bear discussing the latest research on treatments for fragile X syndrome.

Clinical trials of autism treatments rarely use a consistent set of tools to measure efficacy, making it tough to compare the treatments.

An auditory therapy may improve autistic people’s emotional control and help them feel safe enough to engage with the world.